Mentions
Extended reach
Total likes
Video views
AI synopsis
Several posts highlight the promising effects of long-term lithium treatment, emphasizing its ability to reduce tau levels and potentially alter disease progression, often using phrases like 'disease-modifying' and 'significant impact.' The tone suggests excitement about ongoing trials and the broad potential applications of lithium in neurodegenerative conditions, demonstrating both high interest and perceived importance.
Most discussions express support or positive outlooks regarding lithium's potential benefits in treating cognitive impairments.
Posts show high curiosity, mentioning clinical trials, biomarker reductions, and the promise of disease modification.
Discussions include referencing specific studies, mechanisms like tau reduction, and future trials, indicating a moderate depth of engagement.
There is a strong sense that this research could significantly influence Alzheimer's disease treatments and neurodegenerative research.
This is one of over 5,200 clinical efficacy studies on Lithium Carbonate that has been published: "Disease-modifying properties of long-term lithium...". AL001 is our lithium-based compound in Phase IIA trials #alzheimers #bipolar #depression #ptsd $ALZN https://t.co/jYoLNFj7K2
This is one of over 5,200 published research articles regarding Lithium. AL001 is our lithium-based compound, and we expect topline data for the Phase IIA clinical trial in June 2023. #Alzheimers #bipolar #depression #PTSD $ALZN https://t.co/jYoLNFizUu
This is one of over 5,200 clinical efficacy studies on Lithium Carbonate that have been published. AL001 is a patented ionic cocrystal technology delivering a therapeutic combination of lithium, proline, and salicylate #ENDALZ #MentalHealthAwareness $ALZN https://t.co/jYoLNFizUu
This is one of over 5,200 published research articles regarding Lithium. AL001 is our lithium-based compound currently in Phase IIA trials. We expect topline data in Q2. #Alzheimers #bipolar #depression #PTSD $ALZN https://t.co/jYoLNFizUu
リチウムは髄液中のTau濃度も減らしますぞ。調べれば調べるほどすごさを知る。レカネマブとか単純にアミロイドに作用する薬剤よりも複合的にいろいろ作用しそう。https://t.co/mNcCzf7MMz
Disease-modifying properties of long-term lithium treatment foramnestic mild cognitive impairment: randomised controlled trial https://t.co/LRwj44vvQc
Can lithium prevent or even cure Alzheimer's disease? New studies from Harvard and the controversial theories of Dr. Michael Nehls raise intriguing questions. In this video, we explore what really lies behind these…
Its truly amazing how something as small as a mineral might hold a big key to protecting our brain health. This video explores the promising science behind lithium and its potential in combating cognitive decline and…
Lithium, a metal found in smartphone batteries, may help prevent Alzheimer's, stabilize mood, and serve as a biohacking supplement. This video discusses lithium's medical history, its effects on the brain, low-dose…
RT @agingdoc1: Disease-modifying properties of long-term lithium treatment foramnestic mild cognitive impairment: randomised controlled tri…
Disease-modifying properties of long-term lithium treatment foramnestic mild cognitive impairment: randomised controlled trial https://t.co/LRwj44vvQc
Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised cont… https://t.co/m3NQv1hAgG. anel
RT @lecalecata46564: リチウムは髄液中のTau濃度も減らしますぞ。調べれば調べるほどすごさを知る。レカネマブとか単純にアミロイドに作用する薬剤よりも複合的にいろいろ作用しそう。https://t.co/mNcCzf7MMz
リチウムは髄液中のTau濃度も減らしますぞ。調べれば調べるほどすごさを知る。レカネマブとか単純にアミロイドに作用する薬剤よりも複合的にいろいろ作用しそう。https://t.co/mNcCzf7MMz
RT @AlzamendNeuro: This is one of over 5,200 published research articles regarding Lithium. AL001 is our lithium-based compound, and we exp…
This is one of over 5,200 published research articles regarding Lithium. AL001 is our lithium-based compound, and we expect topline data for the Phase IIA clinical trial in June 2023. #Alzheimers #bipolar #depression #PTSD $ALZN https://t.co/jYoLNFizUu
@mal_mars Вы i гугліць развучыліся? randomised controlled trial https://t.co/u2NXjud5l5
This is one of over 5,200 published research articles regarding Lithium. AL001 is our lithium-based compound currently in Phase IIA trials. We expect topline data in Q2. #Alzheimers #bipolar #depression #PTSD $ALZN https://t.co/jYoLNFizUu
RT @AlzamendNeuro: This is one of over 5,200 clinical efficacy studies on Lithium Carbonate that has been published: "Disease-modifying pro…
RT @AlzamendNeuro: This is one of over 5,200 clinical efficacy studies on Lithium Carbonate that has been published: "Disease-modifying pro…
RT @AlzamendNeuro: This is one of over 5,200 clinical efficacy studies on Lithium Carbonate that has been published: "Disease-modifying pro…
This is one of over 5,200 clinical efficacy studies on Lithium Carbonate that has been published: "Disease-modifying properties of long-term lithium...". AL001 is our lithium-based compound in Phase IIA trials #alzheimers #bipolar #depression #ptsd $ALZN https://t.co/jYoLNFj7K2
or as a way to reduce the risk of Alzheimer's disease and other neurodegenerative diseases https://t.co/y265avYOuZ https://t.co/aIqN55lwdF https://t.co/mBB3WHwWLM
RT @AlzamendNeuro: This is one of over 5,200 clinical efficacy studies on Lithium Carbonate that have been published. AL001 is a patented i…
This is one of over 5,200 clinical efficacy studies on Lithium Carbonate that have been published. AL001 is a patented ionic cocrystal technology delivering a therapeutic combination of lithium, proline, and salicylate #ENDALZ #MentalHealthAwareness $ALZN https://t.co/jYoLNFizUu
AI
L
A
JG
F
り
CD
БР
B
MI
DM
KS